Sixth consecutive quarter of year-over-year growth in both Revenue and Adjusted EBITDA (non-GAAP) 1 Third quarter consolidated revenues of $2.51 billion, up 12% on a Reported basis and 9% on an Organic (non-GAAP) 1 basis, with growth in all segments Consolidated GAAP Net Loss Attributable to Bausch Health Companies Inc. of $85 million Consolidated Adjusted EBITDA Attributable to Bausch Health Companies Inc. (non-GAAP) 1 of... Read More